Dubuque Bank & Trust’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Dubuque Bank & Trust’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-12	Closed	-$1K	–	788
2017 Q4	$1K	Hold	12	–	–	﹤0.01%	657
2017 Q3	$1K	Sell	12 -13	-52%	-$761	﹤0.01%	631
2017 Q2	$2K	Buy	+25	New	+$1.42K	﹤0.01%	609

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Dubuque Bank & Trust's BIVV Position: Q1 2018 in Review

Dubuque Bank & Trust sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 12 shares — an estimated $1K sold.

Dubuque Bank & Trust first reported a position in BIVV in Q2 2017 and held it in 3 quarters. The position peaked at $2K in Q2 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Dubuque Bank & Trust reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Dubuque Bank & Trust sold 12 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1K.
Dubuque Bank & Trust first reported a position in Bioverativ Inc. Common Stock in Q2 2017 and held it in 3 quarters.
Dubuque Bank & Trust's Bioverativ Inc. Common Stock position peaked at $2K in Q2 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Dubuque Bank & Trust's 13F filing for Q1 2018, filed 10 May 2018.